Effects of evodiamine on gastrointestinal motility in male rats

European Journal of Pharmacology

Volumn 457, Issue 2-3, 2002, Pages 169-176

  Wu, Chiu Lung ^a   Hung, Chen Road ^b   Chang, Full Young ^c   Lin, Lie Chwen ^d   Pau, K Y Francis ^e   Wang, Paulus S ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cholecystokinin; Devazepide; Evodiamine; Gastrointestinal motility; L 365,260; Lorglumide

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHARCOAL; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHROMIUM; DEVAZEPIDE; EVODIAMINE; LORGLUMIDE; RECEPTOR SUBTYPE; SODIUM DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; PLANT EXTRACT; QUINAZOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CALCULATION; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; GASTROINTESTINAL MOTILITY; GEOMETRY; HORMONE RELEASE; INTESTINE TRANSIT TIME; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STOMACH EMPTYING; ANIMAL; BLOOD; DRUG ANTAGONISM; GASTROINTESTINAL TRANSIT; INTRAPERITONEAL DRUG ADMINISTRATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BENZODIAZEPINONES; CHOLECYSTOKININ; DEVAZEPIDE; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; INJECTIONS, INTRAPERITONEAL; MALE; PHENYLUREA COMPOUNDS; PLANT EXTRACTS; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ;

EID: 0037146890     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02687-0     Document Type: Article

References (50)

1. Anika M.S. Effects of cholecystokinin and caerulein on gastric emptying. Eur. J. Pharmacol. 85:1982;195-199.
2. Beglinger C. Effect of cholecystokinin on gastric motility in humans. Ann. N.Y. Acad. Sci. 713:1994;219-225.
3. Burks T. Actions of drugs on gastrointestinal motility. Johnson L.R. Physiology of the Gastrointestinal Tract. vol. 1:1981;495-516 Raven Press, New York.
4. Chang H.M., But P.P.H. Wuzhuyu. Chang H.M., But P.P.H. Pharmacology and Applications of Chinese Materia Medica. 1986;605-609 World Scientific Publishing, Singapore.
5. Chang F.Y., Lee S.D., Yeh G.H., Wang P.S. Comparison of two orogastric feeding markers for measuring gastrointestinal motor functions in rats. Pharmacology. 49:1994;151-158.
6. Chen T.S., Doong M.L., Chang F.Y., Lee S.D., Wang P.S. Effects of sex steroid hormones on gastric emptying and gastrointestinal transit in rats. Am. J. Physiol. 268:1995;G171-G176.
7. Chen T.S., Doong M.L., Wang S.W., Tsai S.C., Lu C.C., Shih H.C., Chen Y.H., Chang F.Y., Lee S.D., Wang P.S. Gastric emptying and gastrointestinal transit during lactation in rats. Am. J. Physiol. 272:1997;G626-G631.
8. Chey W.Y., Hitanant S., Hendricks J., Lorber S.H. Effect of secretin and cholecystokinin on gastric emptying and gastric output in man. Gastroenterology. 58:1970;820-827.
9. Chiou W.F., Chou C.J., Shum A.Y., Chen C.F. The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur. J. Pharmacol. 215:1992;277-283.
10. Chiou W.F., Sung Y.J., Liao J.F., Shum A.Y., Chen C.F. Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J. Nat. Prod. 60:1997;708-711.
11. Debas H.T., Farooq O., Grossman M.I. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology. 68:1975;1211-1217.
12. Doong M.L., Lu C.C., Kau M.M., Tsai S.C., Chiao Y.C., Chen J.J., Yeh J.Y., Lin H., Huang S.W., Chen T.S., Chang F.Y., Wang P.S. Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats. Br. J. Pharmacol. 124:1998;1123-1130.
13. Fioramonti J., Fargeas M.J., Bertrand V., Pradayrol L., Buéno L. Induction of postprandial intestinal motility and release of cholecystokinin by polyamines in rats. Am. J. Physiol. 267:1994;G960-G965.
14. Grider J.R. Role of cholecystokinin in the regulation of gastrointestinal motility. J. Nutr. 124:1994;1334S-1339S.
15. Herzig K.H. Cholecystokinin- and secretin-releasing peptides in the intestine - a new regulatory interendocrine mechanism in the gastrointestinal tract. Regul. Pept. 73:1998;89-94.
16. Herzig K.H., Schön I., Tatemoto K., Ohe Y., Li Y., Fölsch U.R., Owyang C. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc. Natl. Acad. Sci. 93:1996;7927-7932.
17. Holzer P. Stimulation and inhibition of gastrointestinal propulsion induced by substance P and substance K in the rat. Br. J. Pharmacol. 86:1985;305-312.
18. Hwu C.M., Tsai S.C., Lau C.P., Pu H.F., Wang T.L., Chiang S.T., Wang P.S. Increased concentrations of atrial and plasma atrial natriuretic peptide in castrated male rats. Life Sci. 52:1992;205-212.
19. Innis R.B., Synder S.H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. U. S. A. 77:1980;6917-6921.
20. Jin H.O., Lee K.Y., Chang T.M., Chey W.Y., Dubois A. Physiological role of cholecystokinin on gastric emptying and acid output in dogs. Dig. Dis. Sci. 39:1994;2306-2314.
21. Kopin A.S., Lee Y.M., McBride E.W., Miller L.J., Lu M., Lin H.Y., Kolakowski L.F., Beinborn M. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3605-3609.
22. Li Y., Hao Y., Owyang C. Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. J. Clin. Invest. 105:2000;351-359.
23. Liddle R.A. Regulation of cholecystokinin secretion by intraluminal releasing factors. Am. J. Physiol. 269:1995;G319-G327.
24. Lu L., Huang M., Liu Z., Ma L. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats. NeuroReport. 11:2000;829-832.
25. Makovec F., Bani M., Chiste R., Revel L., Rovati L.C., Setnikar L. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats. Regul. Pept. 16:1986;281-290.
26. Mangel A.W., Koegel A. Effects of peptides on gastric emptying. Am. J. Physiol. 246:1984;G342-G345.
27. Margolis R.L., Moran T.H., McHugh P.R. In vitro response of rat gastrointestinal segments to cholecystokinin and bombesin. Peptides. 10:1989;157-161.
28. Miller M.S., Galligan J.J., Burks T.F. Accurate measurement of intestinal transit in the rat. J. Pharmacol. Methods. 6:1981;211-217.
29. Monstein H.J., Nylander A.G., Salehi A., Chen D., Lundquist I., Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of rat and man. A polymerase chain reaction study. Scand. J. Gastroenterol. 31:1996;383-390.
30. Moran T.H., McHugh P.R. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am. J. Physiol. 242:1982;R491-R497.
31. Moran T.H., Robinson P.H., Goldrich M.S., McHugh P.R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 362:1986;175-179.
32. Moran T.H., Smith G.P., Hostetler A.M., McHugh P.R. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res. 415:1987;149-152.
33. Moran T.H., Kornbluh R., Moore K., Schwartz G.J. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites. Regul. Pept. 52:1994;165-172.
34. Moriarty P., Dimaline R., Thompson D.G., Dockray G.J. Characterization of cholecystokinin A and cholecystokinin B receptors expressed by vagal afferent neurons. Neuroscience. 79:1997;905-913.
35. Murphy R.B., Smith G.P., Gibbs J. Pharmacological examination of cholecystokinin (CCK-8)-induced contractile activity in the rat isolated pylorus. Peptides. 8:1987;127-134.
36. Pisegna J.R., De Weerth A., Huppi K., Wank S.A. Molecular cloning of human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem. Biophys. Res. Commun. 189:1992;296-303.
37. Raybould H.E., Taché Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am. J. Physiol. 255:1988;G242-G246.
38. Reidelberger R.D., O'Rourke M.F. Potent cholecystokinin antagonist L-364,718 stimulates food intake in rats. Am. J. Physiol. 257:1989;R1512-R1518.
39. Rodriguez-Membrilla A., Martinez V., Vergara P. Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat. J. Pharmacol. Exp. Ther. 275:1995;486-493.
40. Ruckebusch M., Fioramonti J. Electrical spiking activity and propulsion in small intestine in fed and fasted rats. Gastroenterology. 68:1975;1500-1508.
41. Silvente-Poirot S., Dufresne M., Vaysse N., Fourmy D. The peripheral cholecystokinin receptors. Eur. J. Biochem. 215:1993;513-529.
42. Spannagel A.W., Green G.M., Guan D., Liddle R.A., Faull K., Reeve J.R. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc. Natl. Acad. Sci. 93:1996;4415-4420.
43. Steel R.D., Torrie J.H. Principles and Procedures of Statistics. 1960;McGraw-Hill, New York.
44. Tang W., Eisenbrand G. Evodia rutaecarpa (Juss.) Benth. Tang W., Eisenbrand G. Chinese Drugs of Plant Origin. 1992;509-514 Springer Verlag, New York.
45. Tsai T.H., Lee T.F., Chen C.F., Wang L.C. Thermoregulatory effects of alkaloids isolated from Wu-chu-yu in afebrile and febrile rats. Pharmacol. Biochem. Behav. 50:1995;293-298.
46. Varga G., Scarpignato C. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists. Eur. J. Pharmacol. 306:1996;153-159.
47. Wank S.A., Pisegna J.R., De Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8691-8695.
48. Yamahara J., Yamada T., Kitani T., Naitoh Y., Fujimura H. Antianoxic action of evodiamine, an alkaloid in Evodia rutaecarpa fruit. J. Ethnopharmacol. 27:1989;185-192.
49. Yang M.C.M., Wu S.L., Kuo J.S., Chen C.F. The hypotensive and negative chronotropic effects of dehydroevodiamine. Eur. J. Pharmacol. 182:1990;537-542.
50. Yu L.L., Liao J.F., Chen C.F. Effect of the crude extract of Evodiae fructus on the intestinal transit in mice. Planta Med. 60:1994;308-312.